DTB Editorial



DTB STAFF

Editor
Ike Iheanacho BSc, MB BS

Deputy Editor
Jenny Blythe MBChB

Associate Editors
Helen Barnett BPharm, MSc, LicAc, MBAcA
Paul McManus BSc, DipClinPharm, MRPharmS
Jacoby Patterson MA Cantab, MB BChir, MFPH, MD
Andrea Tarr BPharm, MSc, MRPharmS

Business Manager
Donna Walton BA, MPhil, DipM, ACIM

Editorial Assistant
Michael Allen BSc

ADVISORY COUNCIL

The Advisory Council members are senior advisors to the Editor of DTB and act as public advocates for DTB. As former or current members of the Editorial Board, they have an in-depth knowledge and experience of DTB policy and processes.

Martin Duerden B Med Sci, MRCGP, Dip Ther, DPH
Conway Local Health Board and Wales College of Medicine, Cardiff University

Wing May Kong PhD, MRCP
Imperial College & Central Middlesex Hospital, London

Prof. Hywel C. Williams BSc, MSc, FRCP, PhD
University Hospital, Nottingham

EDITORIAL BOARD

The Editorial Board alerts and updates DTB about developments in specific areas of practice, help select topics for articles, help steer articles through the editorial process, act as advocates for DTB and help advise on policy where appropriate. Members of the Editorial Board are all practising clinicians.

Ian Anderson MB BS, MD, MRCP, FRCPsych
University of Manchester & Manchester Mental Health & Social Care Trust

Peter Burrill B Pharm, Dip Pres Sci, MRPharmS, FFPMM, MCPP
Derbyshire County PCT

Paul Caldwell MB BS, MRCGP
Goole Health Centre

Ernest H.S. Choy MD, MRCP
GKT School of Medicine, King's College London

Jo Congleton MA, MD, MRCP
Worthing General Hospital

Joanna Girling MA, MB BS, MRCP, FRCOG
West Middlesex University Hospital, London

Aroon Hingorani MA, PhD, FRCP
University College London

Tony Marson MB ChB, MD, FRCP
University of Liverpool and the Walton Centre

Mahdad Noursadeghi MB BS, MRCP, PhD
University College London

George Rylance MB FRCPCH
Royal Victoria Infirmary, Newcastle upon Tyne

Julia K. Schofield FRCP, MRCGP
West Hertfordshire NHS Hospitals Trust

COMMENTATORS

Articles in DTB aim to present a view that incorporates contributions from many people, including both specialists and non-specialists, and organisations. Typically DTB articles are circulated to over 40 individuals and organisations for comment. The draft is then circulated, unsigned, to a range of commentators, including:

  • around 15 independent experts, and any identified from published work or other sources
  • general practitioners
  • pharmacists, including community pharmacists and pharmaceutical advisors
  • nurses, and other healthcare professionals
  • representatives from the medical departments of each company whose drugs have been mentioned
  • in-house DTB editors, DTB Editorial Board and Advisory Council
  • the Medicines and Healthcare products Regulatory Agency (MHRA)
  • British National Formulary (BNF)
  • relevant consumer and patient groups
  • lawyer

If you would like to be considered as a commentator, please send your full contact details and areas of interest to dtbeditor{at}bmjgroup.com